NUVB
Nuvation Bio Inc.
5.63
1 x 5.62
3 x 5.63
bid
ask
+
0.21
3.78%
10:16 AM
timesize
| Ytd | -37.22% | |
| 1y | 174.39% |
5.39
day range
5.72
2.01
52 week range
9.75
| Open | 5.42 | Prev Close | 5.42 | Low | 5.39 | High | 5.72 | Mkt Cap | 1.96B |
| Vol | 1.26M | Avg Vol | 5.50M | EPS | -0.43 | P/E | N/A | Forward P/E | -94.42 |
| Beta | 1.56 | Short Ratio | 10.53 | Inst. Own | 64.86% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-04 | 50-d Avg | 4.95 | 200-d Avg | 5.42 | 1yr Est | 12.33 |
| Income Statement | |||
| Total Revenue | 83.23M | ||
| Revenues (USD) | 83.23M | ||
| Cost of Revenue | 5.99M | ||
| Gross Profit | 77.24M | ||
| Operating Expenses | 73.36M | ||
| Research and Development Expense | 35.05M | ||
| Selling, General and Administrative Expense | 38.31M | ||
| Operating Income | 3.88M | ||
| Interest Expense | 6.71M | ||
| Net Income | 5.40M | ||
| Net Income Common Stock | 5.40M | ||
| Net Income Common Stock (USD) | 5.40M | ||
| Consolidated Income | 5.40M | ||
| Earnings per Basic Share | 0.02 | ||
| Earnings per Basic Share (USD) | 0.02 | ||
| Earnings per Diluted Share | 0.01 | ||
| Earning Before Interest & Taxes (EBIT) | 12.11M | ||
| Earning Before Interest & Taxes (USD) | 12.11M | ||
| Weighted Average Shares | 347.33M | ||
| Weighted Average Shares Diluted | 377.52M | ||
| Balance Sheet | |||
| Cash and Equivalents | 125.39M | ||
| Cash and Equivalents (USD) | 125.39M | ||
| Investments | 408.34M | ||
| Investments Current | 408.34M | ||
| Trade and Non-Trade Receivables | 22.72M | ||
| Current Assets | 591.53M | ||
| Property, Plant & Equipment Net | 4.13M | ||
| Total Assets | 610.24M | ||
| Debt Current | 15.57M | ||
| Total Debt | 216.98M | ||
| Current Liabilities | 79.52M | ||
| Debt Non-Current | 201.41M | ||
| Total Liabilities | 290.68M | ||
| Accumulated Retained Earnings (Deficit) | -1.11B | ||
| Accumulated Other Comprehensive Income | -1.68M | ||
| Shareholders Equity | 319.56M | ||
| Shareholders Equity (USD) | 319.56M | ||
| Assets Non-Current | 18.71M | ||
| Total Debt (USD) | 216.98M | ||
| Goodwill and Intangible Assets | 10.76M | ||
| Inventory | 15.84M | ||
| Liabilities Non-Current | 211.16M | ||
| Trade and Non-Trade Payables | 22.44M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 470.00K | ||
| Net Cash Flow from Financing | 44.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -38.69M | ||
| Capital Expenditure | -48.00K | ||
| Issuance (Purchase) of Equity Shares | 908.00K | ||
| Issuance (Repayment) of Debt Securities | -864.00K | ||
| Net Cash Flow from Investing | -43.64M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -43.59M | ||
| Net Cash Flow from Operations | 5.07M | ||
| Effect of Exchange Rate Changes on Cash | -172.00K | ||
| Share Based Compensation | 9.03M | ||